Biotech Values

[DewDiligence]

4Q21 worldwide Botox sales=$1.30B, +9% QoQ*, +22% YoY:

https://news.abbvie.com/news/press-releases/abbvie-reports-full-year-and-fourth-quarter-2021-financial-results.htm

• US therapeutic: $561M (+5% QoQ, +19% YoY)
• US cosmetic: $397M (+12% QoQ*, +31% YoY)
--
US total: $958M (59% therapeutic; 41% cosmetic) was 74% of worldwide total


• Ex-US therapeutic: $110M (flat QoQ, +14% YoY)
• Ex-US cosmetic: $229M (+21% QoQ*, +27% YoY)
--
Ex-US total: $339M (32% therapeutic; 68% cosmetic) was 26% of worldwide total


*Botox cosmetic sales are seasonally stronger during the second and fourth calendar quarters than the first and third calendar quarters.